Restless Legs Syndrome and Periodic Limb Movements during Sleep

Principles and Practice of Sleep Medicine: Fifth Edition

Volumn , Issue , 2010, Pages 1026-1037

  Montplaisir, Jacques ^a,b   Allen, Richard P ^c   Arthur, Walters ^d,e,f   Ferini Strambi, Luigi ^g,h  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f NEW YORK METHODIST HOSPITAL   (United States)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h Sleep Disorders Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906842805     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6645-3.00090-6     Document Type: Chapter

References (123)

1. Ekbom KA Restless legs. Acta Med Scand 1945, 158(Suppl.):1-123.
2. Allen R, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003, 4:101-119.
3. Michaud M, Chabli A, Lavigne G, et al. Arm restlessness in patients with restless legs syndrome. Mov Disord 2000, 15(2):289-293.
4. Trenkwalder C, Hening W, Walters AS, et al. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord 1999, 14:102-110.
5. Hening WA, Walters AS, Wagner M, et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep 1999, 22:901-912.
6. Michaud M, Dumont M, Selmaoui B, et al. Circadian rhythm of restless legs syndrome symptoms: relationships with salivary melatonin, core body temperature and subjective vigilance. Ann Neurol 2004, 55:372-380.
7. Montplaisir J, Boucher S, Poirier G, et al. Clinical polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Dis 1996, 12(1):61-65.
8. Allen RP, Mignot E, Ripley B, et al. Increased CSF hypocretin-1 (orexin-A) in early- versus late-onset restless legs syndrome (RLS): effects of iron status and amount of activity. Neurology 2002, 58(7 Suppl. 3):A514.
9. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165(11):1286-1292.
10. Pearson VE, Allen RP, Dean T, et al. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006, 7(1):25-30.
11. Winkelmann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002, 52(3):297-302.
12. Whittom S, Dauvilliers Y, Pennestri MH, et al. Age at onset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med 2007, 9:54-59.
13. Botez MI, Lambert B Folate deficiency and restless legs syndrome in pregnancy (letter). N Engl J Med 1977, 297-670.
14. Lavigne G, Montplaisir J Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994, 17(8):739-743.
15. Allen RP, Earley CJ Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001, 18(2):128-147.
16. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004, 164:196-202.
17. Hening W, Walters A, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS Epidemiology, Symptoms, and Treatment) primary care study. Sleep Med 2004, 5(3):237-246.
18. Coleman RM Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. Sleeping and waking disorders: indications and techniques 1982, 265-295. Addison-Wesley, Menlo Park, CA. C. Guilleminault (Ed.).
19. Zucconi M, Ferri R, Allen R, et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 2006, 7(2):175-183.
20. Sforza E, Nicolas A, Lavigne G, et al. EEG and cardiac activation during periodic leg movements in sleep: support for a hierarchy of arousal responses. Neurology 1999, 52(4):786-791.
21. Pennestri MH, Montplaisir J, Colombo R, et al. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007, 68(15):1213-1218.
22. Winkelman WJ, Fynn L, Young T Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006, 7(7):545-552.
23. Winkelman WJ, Shahar E, Sharief I, Gottlieb DJ Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008, 70(1):35-42.
24. Lugaresi E, Cirignotta F, Coccagna G, et al. Nocturnal myoclonus and restless legs syndrome. Adv Neurol 1986, 43:295-307.
25. Pennestri MH, Whittom S, Adam B, et al. PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution. Sleep 2006, 29(9):1183-1187.
26. Coleman RM, Pollak CP, Weitzman ED Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann Neurol 1980, 8:416-421.
27. Karadeniz D, Ondze B, Besset A, et al. Are periodic leg movements during sleep (PLMS) responsible for sleep disruption in insomnia patients?. Eur J Neurol 2000, 7:331-336.
28. Bastuji H, Garcia-Larrea L Sleep/wake abnormalities in patients with periodic leg movements during sleep: factor analysis on data from 24-h ambulatory polygraphy. J Sleep Res 1999, 8:217-223.
29. Nicolas A, Lespérance P, Montplaisir J Is excessive daytime sleepiness with periodic leg movements during sleep a specific diagnostic category?. Eur Neurol 1998, 40:22-26.
30. Michaud M, Paquet J, Lavigne G, et al. Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol 2002, 48:108-113.
31. Haba-Rubio J, Sforza E Test-to-test variability in motor activity during the suggested immobilization test in restless legs patients. Sleep Med 2006, 7(7):561-566.
32. The International Restless Legs Syndrome Study Group Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
33. Walters AS, Picchietti DL, Ehrenberg BL, Wagner ML Restless legs syndrome in childhood and adolescence. Pediatr Neurol 1994, 11:241-245.
34. Kotagal S, Silber MH Childhood-onset restless legs syndrome. Ann Neurol 2004, 56:803-807.
35. Muhle H, Neumann A, Lohmann-Hedrich K, et al. Childhood-onset restless legs syndrome: clinical and genetic features of 22 families. Mov Disord 2008, 23:1113-1121.
36. Laberge L, Tremblay RE, Vitaro F, et al. Development of parasomnias from childhood to early adolescence. Pediatrics 2000, 106:67-74.
37. Walters A, Hickey K, Maltzman J, et al. A questionnaire study of 138 patients with restless legs syndrome: the "Night-Walkers" survey. Neurology 1996, 46:92-95.
38. Picchietti D, Allen RP, Walters AS, et al. Restless legs syndrome: prevalence and impact in children and adolescents-the Peds REST study. Pediatrics 2007, 120:253-266.
39. Sadeh A, Pergamin L, Bar-Haim Y Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies. Sleep Med Rev 2006, 10:381-398.
40. Picchietti DL, England SJ, Walters AS, et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 1998, 13:588-594.
41. Picchietti DL, Underwood DJ, Farris WA, et al. Further studies on periodic limb movement disorder and restless legs syndrome in attention-deficit hyperactivity disorder children. Mov Dis 1999, 14:1000-1007.
42. Chervin RD, Archbold KH, Dillon JE, et al. Associations between symptoms of inattention, hyperactivity, restless legs, and periodic leg movements. Sleep 2002, 25:213-218.
43. Crabtree VM, Ivanenko A, O'Brien LM, et al. Periodic limb movement disorder of sleep in children. J Sleep Res 2003, 12:73-81.
44. Walters AS, Mandelbaum DE, Lewin DS, et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatr Neurol 2000, 22:182-186.
45. Konofal E, Cortese S, Marchand M, et al. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med 2007, 8:711-715.
46. Konofal E, Lecendreux M, Deron J, et al. Effects of iron supplementation on attention deficit-hyperactivity disorder in children. Pediatr Neurol 2008, 38:20-26.
47. Winkelman JW, Chertow GM, Lazarus JM Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996, 28:372-378.
48. Azar SA, Hatefi R, Talebi M Evaluation of effect of renal transplantation in treatment of restless legs syndrome. Transplant Proc 2007, 39:1132-1133.
49. Ondo W, Jankovic J Restless legs syndrome: clinicoetiologic correlates. Neurology 1996, 47:1435-1441.
50. Polydefkis M, Allen RP, Hauer P, et al. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 2000, 55:1115-1121.
51. Iannaccone S, Zucconi M, Marchettini P, et al. Evidence of peripheral neuropathy in primary restless legs syndrome. Mov Dis 1995, 10:2-9.
52. Rutkove SB, Matheson JK, Logigian EL Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 1996, 19:670-672.
53. Weinstock LB, Bosworth BP, Scherl EJ, et al. Crohn's disease is associated with restless legs syndrome. Inflamm Bowel Dis 2010, 16:275-279.
54. Moccia M, Pellecchia MT, Erro R, et al. Restless legs syndrome is a common feature of adult celiac disease. Mov Disord 2010, 25:877-881.
55. Yunus MB, Aldag JC Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 1996, 312:1339.
56. Reynolds G, Blake DR, Pall HS, et al. Restless legs syndrome and rheumatoid arthritis. BMJ 1986, 292:659-660.
57. Ulberg J, Nystrom B Restless legs syndrome in blood donors. Sleep Med 2004, 5:115-118.
58. Kryger MH, Shepertycky M, Foerster J, et al. Sleep disorders in repeat blood donors. Sleep 2003, 26:625-626.
59. Birgegård G, Schneider K, Ulfberg J High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron. Vox Sang 2010 Jun 24, [Epub ahead of print].
60. Waldmann A, Koschizke JW, Leitzmnn C, et al. Dietary iron intake and iron status of German female vegans: results of the German vegan study. Ann Nutr Metab 2004, 48:103-108.
61. Xiong L, Montplaisir J, Desautels A, et al. Family study of restless legs syndrome in Quebec, Canada: clinical characterization of 671 familial cases. Arch Neurol 2010, 67:617-622.
62. Kemlink D, Plazzi G, Vetrugno R, et al. Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 2008, 9(2):75-82.
63. Levchenko A, Montplaisir JY, Asselin G, et al. Autosomal-dominant locus for restless legs syndrome in French-Canadians on chromosome 16p12.1. Mov Disord 2009, 24(1):40-50.
64. Desautels A, Turecki G, Montplaisir J, et al. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology 2001, 57:1304-1308.
65. Desautels A, Turecki G, Montplaisir J, et al. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 2002, 59:215-219.
66. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39(8):1000-1006.
67. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007, 357(7):639-647.
68. Yokata T, Hirose K, Tanabe H, et al. Sleep-related periodic leg movements (nocturnal myoclonus) due to spinal cord lesions. J Neurol Sci 1991, 104:13-18.
69. Dickell MJ, Renfrow SD, Moore PT, et al. Rapid eye movement sleep leg movements in patients with spinal cord injury. Sleep 1994, 17:733-738.
70. Bara-Jimenez W, Aksu M, Graham B, et al. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000, 54:1609-1616.
71. Briellman RS, Rosler KM, Hess CW Blink reflex excitability is abnormal in patients with periodic leg movements in sleep. Mov Dis 1996, 11:710-714.
72. Bucher SS, Seelos KC, Oertel WH, et al. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol 1997, 41:639-645.
73. Tergau F, Wischer S, Paulus W Motor system excitability in patients with restless legs syndrome. Neurology 2002, 52(5):1060-1063.
74. Winkelmann J, Schadrack J, Wetter TC, et al. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med 2001, 2:57-61.
75. Turjanski N, Lees AJ, Brooks DJ Striatal dopaminergic function in restless legs syndrome. Neurology 1999, 52:932-937.
76. 2-receptor binding. Brain 2006, 129(Pt 8):2017-2028.
77. Eisensehr I, Wetter TC, Linke R, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2001, 57(7):1307-1309.
78. Tribl GG, Asenbaum S, Klosch G, et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome (letter to editor). Neurology 2002, 59(4):649-650.
79. Michaud M, Soucy JP, Chabli A, et al. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome. J Neurol 2002, 249:164-170.
80. Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000, 54(2):502-504.
81. Earley CJ, Hyland K, Allen RP CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome. Mov Disord 2001, 16(1):144-149.
82. Stiasny-Kolster K, Moller JC, Zschocke J, et al. Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients. Mov Disord 2004, 19(2):192-196.
83. Allen RP, Connor JR, Hyland K, Earley CJ Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis. Sleep Med 2009, 10(1):123-128.
84. Montplaisir J, Lorrain D, Godbout R Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. Eur Neurol 1991, 31:41-43.
85. 11C diprenorphine PET study. Brain 2005, 128:906-917.
86. Walters AS, Ondo WG, Le W Endogenous opioid levels are decreased in thalamus of restless legs syndrome patients compared to controls: a post-mortem study. Sleep 2008, 31(Abs Suppl):A266.
87. Allen RP, Mignot E, Ripley B, et al. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Neurology 2002, 59(4):639-641.
88. Allen RP, Lesage S, Earley CJ Antihistamines and benzodiazepines exacerbate daytime restless legs syndrome (RLS) symptoms (abstract). Sleep 2005, 28:A279.
89. Ekbom KA Restless legs syndrome. Neurology 1960, 10:868-873.
90. Nordlander NB Therapy in restless legs. Acta Med Scand 1953, 145:453-457.
91. Earley CJ, Heckler D, Horská A, et al. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 2004, 5(3):231-235.
92. Kryger MH, Otake K, Foerster J Low body stores of iron on restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers. Sleep Med 2002, 3(2):127-132.
93. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000, 54(8):1698-1700.
94. Allen RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001, 56(2):263-265.
95. Godau J, Schweitzer KJ, Liepelt I, et al. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov Disord 2007, 22(2):187-192.
96. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005, 58(4):630-634.
97. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61:304-309.
98. Hening W, Allen R, Earley C, et al. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999, 22:970-999.
99. Early CJ, Allen RP Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996, 19:801-810.
100. Garcia-Borreguero D, Allen RP, Kohnen R, et al. Diagnosic standards for dopaminergic augmentation of restless legs syndrome: report from World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007, 8:520-530.
101. Garcia-Borreguero D, Kohnen R, Hogl B, et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levo-dopa in RLS. Sleep Med 2007, 8:455-463.
102. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999, 52:944-950.
103. Stiasny K, Wetter TC, Winkelmann J, et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 2001, 56(10):1399-1402.
104. 2-agonist cabergoline-an open clinical trial. Sleep 2000, 23(3):349-354.
105. Antonini A, Poewe W Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. Lancet Neurol 2007, 6:826-829.
106. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B RLS improved by pramipexole: a double-blind randomized trial. Neurology 1999, 52(5):938-943.
107. Oertel WH, Stiasny-Kolster K, Bergtholdt B, et al. Efficacy of pramipexole in RLS: a six-week, multicenter, randomized, double-blind study. Mov Disord 2007, 22:213-219.
108. Silber MH, Girish M, Izurieta R Pramipexole in the management of restless legs syndrome: an extended study. Sleep 2003, 26(7):819-821.
109. Winkelman JW, Johnston L Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome. Sleep Med 2004, 5:9-14.
110. Montplaisir J, Fantini ML, Desautels A, et al. Long-term treatment with pramipexole in restless legs syndrome. Eur J Neurol 2006, 13:1306-1311.
111. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Therapy with ropinirole, efficacy and tolerability in RLS-1 Study Group. Ropinirole in the treatment of RLS: results from the TREAT RLS-1 study, a 12-week, randomized, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004, 75:92-97.
112. Montplaisir J, Karrasch J, Haan J, Volc D Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord 2006, 21:1627-1635.
113. Garcia-Borreguero D, Grunstein R, Sridhar G, et al. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Med 2007, 8:742-752.
114. Stiasny K, Möller JC, Oertel WH Safety of pramipexole in patients with restless legs syndrome. Neurology 2000, 55(10):1589-1590.
115. Driver-Dunckley ED, Noble BN, Hentz JG, et al. Gambling and increased sexual desire with dopaminergic medications in restless lets syndrome. Clin Neuropharmacol 2007, 30(5):249-255.
116. Trenkwalder C, Benes H, Poewe W, et al. Efficacy of rotigotine for treatment of moderate to severe restless legs syndrome: a randomized, double-blind, placebo-controlled study. Lancet Neurol 2008, 7:595-604.
117. Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993, 16:327-332.
118. Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Dis 2001, 6:1105-1109.
119. Ondo WG Methadone for refractory restless legs syndrome. Mov Disord 2005, 20:345-348.
120. Garcia-Barreguero D, Larrosa de la Liave Y, Verger K, et al. Treatment of restless legs syndrome with gabapentin. Neurology 2002, 59:1573-1579.
121. Earley CJ, Horská A, Mohamed MA, et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10(2):206-211.
122. Grote L, Leissner L, Hedner J, Ulfberg J A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009, 24:1445-1452.
123. Ondo WG Intravenous iron dextran for severe refractory restless legs syndrome. Sleep Med 2010, 11(5):494-496.